CD4+ T cells engrafted with a recombinant immunoreceptor efficiently lyse target cells in a MHC antigen- and Fas-independent fashion
- PMID: 11441120
- DOI: 10.4049/jimmunol.167.2.1090
CD4+ T cells engrafted with a recombinant immunoreceptor efficiently lyse target cells in a MHC antigen- and Fas-independent fashion
Abstract
T cells engrafted by a recombinant immunoreceptor with predefined Ag specificity can efficiently lyse Ag-positive target cells in a MHC Ag-independent manner. It is yet unresolved how receptor-grafted CD4+ T cells contribute to MHC Ag-independent target cell lysis. To address this issue, we grafted isolated CD8+ and CD4+ T cells from the peripheral blood with recombinant anti-carcinoembryonic Ag and anti-CD30 receptors, respectively. Cytotoxicity analyses revealed that grafted CD4+ T cells exert cytolysis of Ag-positive target cells with an efficiency similar to that of grafted CD8+ T cells. Lysis by receptor-grafted CD4+ T cells is Ag specific and is inhibited by blocking the target Ag or the Ag binding site of the recombinant receptor. Both Fas-sensitive and Fas-resistant target cells are lysed with equal efficiency, and lysis of Fas-sensitive target cells is not blocked by an anti-Fas ligand Ab, indicating that cytolysis by receptor-grafted CD4+ T cells is independent of the Fas pathway. We conclude that cytolysis by CD4+ T cells equipped with a recombinant immunoreceptor is MHC Ag and Fas independent and likely to be mediated by perforin present in receptor-grafted CD4+ T cells.
Similar articles
-
Human CD4+ T cells lyse target cells via granzyme/perforin upon circumvention of MHC class II restriction by an antibody-like immunoreceptor.J Immunol. 2006 Oct 15;177(8):5668-75. doi: 10.4049/jimmunol.177.8.5668. J Immunol. 2006. PMID: 17015756
-
Essential roles of perforin in antigen-specific cytotoxicity mediated by human CD4+ T lymphocytes: analysis using the combination of hereditary perforin-deficient effector cells and Fas-deficient target cells.J Immunol. 2003 Feb 15;170(4):2205-13. doi: 10.4049/jimmunol.170.4.2205. J Immunol. 2003. PMID: 12574394
-
IL-4 diminishes perforin-mediated and increases Fas ligand-mediated cytotoxicity In vivo.J Immunol. 2000 Apr 1;164(7):3487-93. doi: 10.4049/jimmunol.164.7.3487. J Immunol. 2000. PMID: 10725701
-
How do cytotoxic lymphocytes kill their targets?Curr Opin Immunol. 1998 Oct;10(5):581-7. doi: 10.1016/s0952-7915(98)80227-6. Curr Opin Immunol. 1998. PMID: 9794837 Review.
-
Fas- and perforin-independent mechanism of cytotoxic T lymphocyte.Immunol Res. 1998;17(1-2):89-93. doi: 10.1007/BF02786434. Immunol Res. 1998. PMID: 9479571 Review.
Cited by 8 articles
-
Chimeric Antigen Receptor T-Cell Therapy for the Community Oncologist.Oncologist. 2016 May;21(5):608-17. doi: 10.1634/theoncologist.2015-0421. Epub 2016 Mar 23. Oncologist. 2016. PMID: 27009942 Free PMC article. Review.
-
Extending the lifespan and efficacies of immune cells used in adoptive transfer for cancer immunotherapies-A review.Oncoimmunology. 2015 Mar 19;4(4):e1002720. doi: 10.1080/2162402X.2014.1002720. eCollection 2015 Apr. Oncoimmunology. 2015. PMID: 26155387 Free PMC article. Review.
-
Antigen-Specific T-Cell Activation Independently of the MHC: Chimeric Antigen Receptor-Redirected T Cells.Front Immunol. 2013 Nov 11;4:371. doi: 10.3389/fimmu.2013.00371. eCollection 2013. Front Immunol. 2013. PMID: 24273543 Free PMC article. Review.
-
Focus on adoptive T cell transfer trials in melanoma.Clin Dev Immunol. 2010;2010:260267. doi: 10.1155/2010/260267. Epub 2010 Dec 26. Clin Dev Immunol. 2010. PMID: 21234353 Free PMC article. Review.
-
Chimeric antigen receptor-engineered T cells for immunotherapy of cancer.J Biomed Biotechnol. 2010;2010:956304. doi: 10.1155/2010/956304. Epub 2010 May 5. J Biomed Biotechnol. 2010. PMID: 20467460 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous